Hindustan Unilever Ltd (HUL) is sharpening its strategic focus on the fast-growing Health & Wellbeing (H&W) segment through two major portfolio actions: deepening its bet on OZiva while exiting a non-core minority investment. Together, the moves underline the company’s intent to scale fewer, larger brands with clear leadership potential in emerging consumer categories.
The FMCG major has approved the acquisition of the remaining 49% stake in Zywie Ventures Private Limited (OZiva) for a consideration of ₹824 crore, making the plant-based nutrition and wellness brand a wholly owned subsidiary. In parallel, HUL will divest its 19.8% minority stake in Nutritionalab Pvt Ltd to USV Pvt Ltd for ₹307 crore. Both transactions are expected to be completed by March 2026, subject to customary approvals.
HUL entered the Health & Wellbeing space in 2023, positioning it as a key long-term growth engine amid rising consumer focus on preventive health, nutrition, and everyday wellness. OZiva has emerged as the company’s most successful play in this segment. Following HUL’s majority investment of 51%, the brand has scaled rapidly, reaching revenues of approximately ₹480 crore in 2025 and delivering a robust CAGR of around 130% over the past two years.
The strong performance reflects a combination of portfolio innovation, premium positioning, and the ability to leverage HUL’s scale advantages across distribution, supply chain, and market development. Full ownership is expected to further accelerate OZiva’s growth by enabling deeper integration with HUL’s R&D, science-led product development, and omnichannel reach, while allowing faster decision-making in a highly competitive category.
At the same time, the exit from Nutritionalab signals a disciplined approach to capital allocation. By divesting a minority stake where strategic control and scaling potential are limited, HUL is reinforcing its stated strategy of portfolio transformation, prioritising fewer, bigger bets that can move the needle at scale. The ₹307-crore divestment also releases capital that can be redeployed into high-conviction growth platforms such as Health & Wellbeing.
Commenting on the strategic rationale, CEO and Managing Director Priya Nair highlighted the centrality of wellness to HUL’s future growth agenda. She noted that full ownership of OZiva reflects the company’s confidence in the category’s long-term potential and its ability to build purpose-led brands by leveraging HUL’s strengths in science, distribution, and market development.
Overall, the two transactions mark a clear inflection point in HUL’s Health & Wellbeing journey. By consolidating ownership in a high-growth brand while streamlining its broader investment portfolio, HUL is positioning itself to capture evolving consumer demand for holistic wellness, while maintaining strategic focus, financial discipline, and scalability in one of FMCG’s most promising frontiers.